Technologies Overview is a topic within the NeuroWiki knowledge base covering aspects of neurodegenerative disease research and mechanisms.
This section covers technologies used in neurodegenerative disease research and treatment, spanning therapeutic interventions, diagnostic methods, and research tools.
Gene therapy approaches deliver genetic material to modify disease processes. Key technologies include:
- AAV Vectors — Adeno-associated virus vectors for safe, long-term gene delivery
- CRISPR-Cas9 — Gene editing to correct mutations or modify gene expression
- RNA Interference — Silencing disease-causing genes
Gene therapy for neurodegenerative diseases targets monogenic disorders and aims to deliver neuroprotective factors. Clinical trials are underway for Parkinson's, Alzheimer's, and ALS.
Neuromodulation uses electrical or chemical stimulation to modify neural activity:
DBS is clinically approved for Parkinson's disease and essential tremor. TMS shows promise for Alzheimer's and depression.
Effective CNS drug delivery remains challenging due to the blood-brain barrier:
Neuroimaging provides structural and molecular information:
Sensitive detection enables early diagnosis:
See Technology Rankings for a ranked list by therapeutic potential and development stage.
Modern neurodegenerative disease research increasingly combines multiple technologies:
Combining genomics, transcriptomics, proteomics, and metabolomics provides comprehensive disease understanding. Single-cell approaches reveal cell-type specific changes impossible to detect in bulk tissue.
¶ Imaging and Biomarker Correlation
Linking PET amyloid/tau imaging with CSF and plasma biomarkers enables validation of fluid biomarkers against ground-truth imaging. This accelerates biomarker development and clinical qualification.
iPSC-derived neurons from patient samples enable disease modeling with human genetics. Combined with CRISPR editing, isogenic cell lines reveal mutation-specific effects.
The technology landscape continues evolving:
- Spatial Biology: Mapping molecular changes within intact tissue architecture
- Proteomics: Next-gen proteomics identifying thousands of proteins
- Neural Interfaces: High-density electrode arrays for circuit mapping
- AI/ML: Deep learning for image analysis, biomarker discovery, patient stratification
See all 107 technologies pages...
- Technologies Overview — This page
- Technologies Rankings — Ranked list by research activity
- Technologies Dashboard — Data visualizations and metrics
- Total Pages: 107 Technologies pages in this section
- Last Updated: This section is actively maintained
- AI-Decoded Neural Intent Brain-Computer Interfaces
- ALS Communication Brain-Computer Interfaces
- Acoustoelectric Brain Imaging
- Adaptive Deep Brain Stimulation (DBS) Technology
- Allen Brain Atlas API for Neurodegeneration Workflows
- AllenSDK in Neurodegeneration Research
- AlphaFold for Neurodegenerative Diseases
- Antisense Oligonucleotide Therapy in Neurodegeneration
- Artificial Intelligence for Neurodegeneration Research
- Artificial Intelligence in Neurodegeneration Research
- BCI Clinical Trials for Neurodegenerative Diseases
- BCI Clinical Trials for Neurodegenerative Diseases
- BCI for Alzheimer's Disease
- BCI for FTD Behavioral Circuit Modulation
- BCI for Multiple Sclerosis
- BCI-Assisted Rehabilitation
- Biointegrated Neural Interfaces
- Bitbrain Brain-Computer Interface
- Blackrock Neurotech
- Blackrock Neurotech — Brain-Computer Interface
- Brain Knowledge Platform
- Brain Organoid-Silicon Interface Technology
- Brain Organoids
- Brain Organoids for Neurodegeneration Research
- Brain-Computer Interface Technologies
- Brain-Computer Interface Technologies
- Brain-Computer Interface Technology
- Brain-Computer Interface Technology Landscape
- Brain-Computer Interface for Frontotemporal Dementia
- Brain-Computer Interface for Huntington's Disease
See all 107 technologies pages...